To view this email as a web page, click here.

 
Managing ophthalmic surgery patients on antithrombotic drugs
Study authors proposed their pathway for managing patients taking antithrombotic drugs. For low-risk procedures—sub-Tenon/topical cataract, corneal, chalazion, eyelid cyst/lesion removal, and strabismus surgeries—antiplatelets can be continued.
Read more
ADVERTISEMENT
 
Determining DR progression: Much work still needs to be done
The worldwide incidence of diabetes has been increasing markedly, and by 2014 it had increased to 422 million individuals from 108 million only 34 years previously.
Read more
ADVERTISEMENT
 
Sustained-release implant promising for long-term IOP reduction
Dr E. Randy Craven discusses sustained-release implants for long-term IOP reduction.
Read more
ADVERTISEMENT
 
RELATED ARTICLES
 
Nerve growth factor promising for dry eye
OPS at 50: How imaging led to birth of new profession
Considering BID ocular steroid post-cataract surgery
Primary posterior optic capture offers many advantages in cataract surgery
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.